MSN Laboratories initiates phase-III trial of Molnupiravir

Clinical trials will be performed on more than 2,400 subjects suffering from mild-to-moderate Covid-19

Comments

Popular posts from this blog

Karnataka court issues summons to Yediyurappa in POCSO case

Bengaluru: Bus conductor fails to return Rs 1; court orders BMTC to pay Rs 3K as compensation

MUDA case: Karnataka HC rejects Siddaramaiah’s plea against Governor move